(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)methanol, 95.0%, 5g

(R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid, 98.0%, 100mg

5-Bromo-1H-indole-7-carboxylic acid, 97.0%, 100g

2,2'-(1,4-Diazepane-1,4-diyl)bis(ethane-1-sulfonic acid), 98%, 1g

4-Amino-3-methyl-5-nitrobenzoic acid, 98%, 1g

Ethyl 4-ethylbenzoate, 1g

Methyl 4-(4-chlorophenyl)-3-(chlorosulfonyl)-5-(trifluoromethyl)thiophene-2-carboxylate, 95.0%, 500mg

(2-Fluoro-4-(trifluoromethoxy)phenyl)boronic acid, 95.0%, 100mg

3-Bromo-2-methoxybenzaldehyde, 95.0%, 1g

2-((2S,5S)-5-methyl-3,6-dioxopiperazin-2-yl)acetic acid, 95.0%, 250mg

5-Oxa-2,7-diazaspiro[3.4]octan-6-one, 98%, 25mg

2-(3,5-Bis(trifluoromethyl)phenyl)-2-methylpropanoic acid, 95.0%, 10g

Recipiente de cristalización DURAN® sin pico, 100 ml, 70 mm, 10 Unidad(es)